Skip to main content
. 2023 Dec 15;23(24):9842. doi: 10.3390/s23249842

Figure 1.

Figure 1

Challenges in glioma research, such as drug accessibility, lack of reliable biomarkers, recurrent resistance of the treatment, progression vs. pseudoprogression, and intertumoral and intratumoral heterogeneity (created with the free trail of BioRender).